The Latest Trends in Biopharma Partnering

07:40 AM - 08:40 AM Registration And Networking Breakfast

08:40 AM - 08:45 AM Welcoming Remarks

, ,

08:45 AM - 09:00 AM Chairperson’s Opening Address

Jonathan Gertler, Managing Partner & CEO, Back Bay Life Science Advisors

img

Jonathan Gertler

Managing Partner & CEO
Back Bay Life Science Advisors
Kick-start your partnering experience meeting those who prioritize the same therapeutic areas as you! Find out the latest priorities in the biggest therapeutic areas and current opportunities available. Discuss goals, common industry challenges and firm up your personal partnering objectives for the next three days.

#1 Oncology
Todd Haim, Program Director, NIH, National Cancer Institute, Small Business Innovation Research (SBIR) Development Center

#2 Immunology

Kia Motesharei, Head, Global Licensing & Business Development, Immunology, Merck KGaA, Darmstadt, Germany

#3 Immuno-oncology

Paul Resnick, Vice President and Chief Business Officer, MabVax Therapeutics, Inc.

#4 Rare and Orphan Diseases
Joe Whalen, Senior Vice President, Business Development & Alliance Management, Horizon Pharma

#5 Pain
Kathryn Gregory, Executive Director, Business Development, Purdue Pharma

#6 Gene Therapy
Jeremy Ahouse, Executive Director, Business Development & Global Alliances, Celgene

#7 Diabetes
Christoph Pittius, Vice President, Head of Transactions, AstraZeneca

#8
Neurodegenerative Diseases

img

Todd Haim

Program Director
NIH, National Cancer Institute, Small Business Innovation Research (SBIR) Development Center
img

Joe Whalen

Senior Vice President, Business Development and Alliance Management
Horizon Pharma
img

Kia Motesharei

Head, Global Licensing & Business Development, Immunology
EMD Serono / Merck KGaA
img

Paul Resnick

Vice President and Chief Business Officer
MabVax Therapeutics
img

Kathryn Gregory

Executive Director, Business Development
Purdue Pharma

09:20 AM - 09:35 AM Biotech Spotlight | Heracles Pharma

Jim Vail, Director of Business Development, Heracles Pharma

img

Jim Vail

Director of Business Development
Heracles Pharma

09:35 AM - 09:50 AM Biotech Spotlight | Sorrento Therapeutics

Henry Ji, President and Chief Executive Officer, Sorrento Therapeutics


img

Henry Ji

President and Chief Executive Officer
Sorrento Therapeutics
• What are the latest opportunities for immunology in areas such as cell therapy?
• Just how many immunotherapies can you put checkpoints on top of?
• What are the newest opportunities for combination therapies in immunology?


img

Prakash Raman

Vice President, Global Head of Oncology BD&L
Novartis
img

Christian Hordo

Head of Business Development
Juno Therapeutics
img

Paul Resnick

Vice President and Chief Business Officer
MabVax Therapeutics
img

Michael Woo

Director, Search & Evaluation, ImmunoOncology
Merck KGaA, Darmstadt, Germany
img

Michelle B. Hoffmann

Senior Vice President
Back Bay Life Science Advisors

1:1 Partnering Meetings

09:50 AM - 10:30 AM Opening Of 1:1 Partnering Meetings



General Session

10:30 AM - 11:00 AM Networking And Refreshment Break

1:1 Partnering Meetings

10:30 AM - 11:00 AM Opening Of 1:1 Partnering Meetings



• Which areas are ripe for cell and gene therapy, which areas are inapplicable?
• How are new deals being developed for these new technologies?
• With a curative approach, what is the future for cell and gene therapy?


img

Hemmie Chang

Chair, Licensing & Strategic Alliances Practice Group
Foley Hoag
img

Simon Bateman

Executive Director, Business Development & Licensing, Alliance Management
Novartis
img

Jeremy Ahouse

Executive Director, Alliance Management
Celgene Corporation
img

Lawrence Klein

Vice President, Strategy
CRISPR Therapeutics

1:1 Partnering Meetings

11:00 AM - 11:40 AM Opening Of 1:1 Partnering Meetings





img

Todd Haim

Program Director
NIH, National Cancer Institute, Small Business Innovation Research (SBIR) Development Center

1:1 Partnering Meetings

11:40 AM - 11:45 AM Opening Of 1:1 Partnering Meetings



General Session

11:45 AM - 12:00 PM Biotech Spotlight | CellSight

Aruna Gambhir, Chief Executive Officer, CellSight
Hear from innovative oncology focused biotech companies who will provide a 15 minute overview of their latest technologies. Find out the latest innovations that could be critical to your next deal, or demonstrate your technology to an audience looking for their next deal.


Aruna Gambhir

Chief Executive Officer
CellSight

1:1 Partnering Meetings

11:45 AM - 12:00 PM Opening Of 1:1 Partnering Meetings

General Session

12:00 PM - 12:15 PM Biotech Spotlight | CerRx

Bill Simpson, Chief Executive Officer, CerRx
Hear from innovative oncology focused biotech companies who will provide a 15 minute overview of their latest technologies. Find out the latest innovations that could be critical to your next deal, or demonstrate your technology to an audience looking for their next deal.


img

Bill Simpson

Chief Executive Officer
CerRx

1:1 Partnering Meetings

12:00 PM - 12:15 PM Opening Of 1:1 Partnering Meetings

General Session

12:15 PM - 12:30 PM Biotech Spotlight | Humanetics

Ron Zenk, Chief Executive Officer, Humanetics
Hear from innovative oncology focused biotech companies who will provide a 15 minute overview of their latest technologies. Find out the latest innovations that could be critical to your next deal, or demonstrate your technology to an audience looking for their next deal.


img

Ron Zenk

Chief Executive Officer
Humanetics

1:1 Partnering Meetings

12:15 PM - 12:30 PM Opening Of 1:1 Partnering Meetings

General Session

12:30 PM - 12:45 PM Biotech Spotlight | JSK Therapeutics

Paul Shami, Chief Medical Officer, JSK Therapeutics
Hear from innovative oncology focused biotech companies who will provide a 15 minute overview of their latest technologies. Find out the latest innovations that could be critical to your next deal, or demonstrate your technology to an audience looking for their next deal.


img

Paul Shami

Chief Medical Officer
JSK Therapeutics

1:1 Partnering Meetings

12:30 PM - 12:45 PM Opening Of 1:1 Partnering Meetings

General Session

12:45 PM - 1:00 PM Biotech Spotlight | Keystone Nano

Jeff Davidson, Chief Executive Officer, Keystone Nano
Hear from innovative oncology focused biotech companies who will provide a 15 minute overview of their latest technologies. Find out the latest innovations that could be critical to your next deal, or demonstrate your technology to an audience looking for their next deal.


img

Jeff Davidson

Chief Executive Officer
Keystone Nano

1:1 Partnering Meetings

12:45 PM - 1:00 PM Opening Of 1:1 Partnering Meetings

1:00 PM - 2:00 PM Networking Luncheon



• Where can you find money in public markets currently?
• What creative financing is being done?
• How are companies finding money to launch?


img

Joe Whalen

Senior Vice President, Business Development and Alliance Management
Horizon Pharma
img

Timothy Morris

Chief Financial Officer, Head of Business Development
AcelRx Pharmaceuticals Inc
img

Robert Breuil

Chief Financial Officer
Corium International, Inc.
img

Luke Düster

Managing Director
CRG

1:1 Partnering Meetings

2:00 PM - 2:40 PM 1:1 Partnering Meetings



• What are the top 5 do’s and don’ts for the pitch deck?
• What is the process for getting on their radar?
• How do you effectively progress discussions?


img

Monica Viziano

Senior Director, Alliance Management, Corporate Development
Gilead Sciences
img

Kia Motesharei

Head, Global Licensing & Business Development, Immunology
EMD Serono / Merck KGaA
img

Neil Berkley

Senior Director, Business Development
GSK
img

Greg Benning

Managing Director, Head of Financial Advisory
Back Bay Life Science Advisors
img

Kevin Anderson

Director, Global Business Development, Immunology, Inflammation & Infectiou
Roche
img

Klaus Damm

Director, Search and Evaluation, Oncology
Abbvie

1:1 Partnering Meetings

2:40 PM - 3:20 PM 1:1 Partnering Meetings



General Session

3:20 PM - 3:50 PM Networking And Refreshment Break



1:1 Partnering Meetings

3:20 PM - 3:50 PM 1:1 Partnering Meetings



General Session

3:50 PM - 4:05 PM Biotech Spotlight | Signpath Pharma

Kai Larson, Vice President, Business Development, COO, Signpath Pharma

img

Kai Larson

Vice President, Business Development, COO
Signpath Pharma

1:1 Partnering Meetings

3:50 PM - 4:05 PM 1:1 Partnering Meetings



General Session

4:05 PM - 4:20 PM Biotech Spotlight | Paranta Biosciences

Ross Barrow, Chief Executive Officer, Paranta Biosciences

img

Ross Barrow

Chief Executive Officer
Paranta Biosciences

1:1 Partnering Meetings

4:05 PM - 4:20 PM 1:1 Partnering Meetings



General Session

4:20 PM - 4:35 PM Biotech Spotlight

Wonsuk Yang, Chief Executive Officer, GtreeBNT Co., Ltd.


img

Wonsuk Yang

Chief Executive Officer
GtreeBNT Co., Ltd.

1:1 Partnering Meetings

4:20 PM - 4:35 PM 1:1 Partnering Meetings



General Session

4:35 PM - 4:50 PM Biotech Spotlight | Tapimmune

John Bonfiglio, President & COO, Tapimmune

img

John Bonfiglio

President & COO
Tapimmune

1:1 Partnering Meetings

4:35 PM - 4:50 PM 1:1 Partnering Meetings



• How do different innovation hubs compete or differentiate themselves?
• What is the role of geography and how can geography be used for advantage?
• What is next on the horizon for innovation centers?


img

Chris Leo

SVP
Back Bay Life Science Advisors
img

Neena Kadaba

Director, Industry Alliances
QB3
img

Barbara Araneo

Innovation Sourcing Director
Novo Nordisk
img

Melinda Richter

Head of JLABS
Janssen R&D US
img

Alex Szidon

Executive Director, Business Development & Licensing, Head, West Coast Inno
Merck
img

Heather Wasserman

Senior Director
Eli Lilly and Company

1:1 Partnering Meetings

4:50 PM - 5:30 PM 1:1 Partnering Meetings



5:30 PM - 11:59 PM Sunset Cocktail Reception